Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges - Annals of Oncology
Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience | Anticancer Research
The concept of neoadjuvant therapy in breast cancer - OWise UK
Cureus | Role of Neoadjuvant Chemotherapy in Locally Advanced Carcinoma Stomach: An Analysis of the Short-Term Outcomes | Article
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
JPM | Free Full-Text | Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink
Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer | Journal of Nuclear Medicine
Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer | NEJM
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy - ScienceDirect
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
Frontiers | The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients - Annals of Oncology
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
Assessment of The breast After Neoadjuvant Treatment
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer - Advances in Radiation Oncology
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
![PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2a5cff93f34ad2baa7b2ce48db639064f71d844d/5-Table3-1.png "PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar")
PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
